Mankind Pharma Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Mankind Pharma has a total shareholder equity of ₹95.8B and total debt of ₹2.1B, which brings its debt-to-equity ratio to 2.2%. Its total assets and total liabilities are ₹119.6B and ₹23.9B respectively. Mankind Pharma's EBIT is ₹21.6B making its interest coverage ratio -313.5. It has cash and short-term investments of ₹33.9B.
Informazioni chiave
2.2%
Rapporto debito/patrimonio netto
₹2.07b
Debito
| Indice di copertura degli interessi | -313.5x |
| Contanti | ₹33.86b |
| Patrimonio netto | ₹95.76b |
| Totale passività | ₹23.87b |
| Totale attività | ₹119.63b |
Aggiornamenti recenti sulla salute finanziaria
Recent updates
Here's Why Mankind Pharma (NSE:MANKIND) Can Manage Its Debt Responsibly
Aug 26
Risks To Shareholder Returns Are Elevated At These Prices For Mankind Pharma Limited (NSE:MANKIND)
Jul 12Here's Why Mankind Pharma (NSE:MANKIND) Has Caught The Eye Of Investors
May 08Mankind Pharma Limited's (NSE:MANKIND) Business Is Trailing The Market But Its Shares Aren't
Apr 08Mankind Pharma Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 04Analisi della posizione finanziaria
Passività a breve termine: MANKIND's short term assets (₹65.7B) exceed its short term liabilities (₹21.2B).
Passività a lungo termine: MANKIND's short term assets (₹65.7B) exceed its long term liabilities (₹2.7B).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: MANKIND has more cash than its total debt.
Riduzione del debito: MANKIND's debt to equity ratio has reduced from 7.5% to 2.2% over the past 5 years.
Copertura del debito: MANKIND's debt is well covered by operating cash flow (1039%).
Copertura degli interessi: MANKIND earns more interest than it pays, so coverage of interest payments is not a concern.